Grace Therapeutics, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Grace Therapeutics, Inc. (GRCE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $23.00 thousand for the 6-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-11-13
- Grace Therapeutics, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2023-09-30 was $10.00K.
- Grace Therapeutics, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2023-06-30 was $13.00K.
- Grace Therapeutics, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2022-09-30 was $0.00.
- Grace Therapeutics, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2022-06-30 was $0.00.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month |
|---|---|---|
| 2023-09-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $23.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $13.00K 10-Q · filed 2023-08-11 | |
| 2022-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |